Latest Regulatory News

Karoon Energy has successfully acquired 100% interests in six offshore blocks in Brazil’s Santos Basin, reinforcing its strategic position and increasing its 2025 capital expenditure guidance to US$120-140 million.

Blaze Minerals has inked a binding deal to acquire a major interest in the Loulombo Base Metals Project in the Republic of Congo, backed by a $2.52 million capital raise to fund exploration and development.

Morella Corporation has initiated a pioneering rubidium extraction study with Edith Cowan University and secured key approvals for development drilling at its Mt Edon Project, setting the stage for a maiden mineral resource estimate.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

CLINUVEL’s Phase II pilot study reveals afamelanotide monotherapy does not trigger repigmentation in vitiligo patients, underscoring the necessity of adjunct NB-UVB phototherapy.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has secured a significant supply agreement to enter Germany’s burgeoning medical cannabis market, promising at least A$5.6 million in revenue for FY2026.

Alligator Energy advances regulatory approvals and construction preparations for its Samphire Uranium Project’s Field Recovery Trial, a critical step toward commercial production.

Estrella Resources has ramped up its manganese exploration at the Ira Miri Project in Timor-Leste with a more powerful diamond drill rig and a fresh supergene manganese outcrop discovery, setting the stage for an extensive drilling program.

Platinum Asset Management and L1 Capital have advanced their merger talks, completing due diligence and proposing a revised ownership structure favoring L1 Capital shareholders. The deal also outlines a nuanced performance fee arrangement tied to L1’s Long Short funds.

Bastion Minerals has launched a non-renounceable rights issue to raise up to $677,721, offering eligible shareholders in Australia and New Zealand the chance to increase their holdings at a minimal price. The capital will support ongoing project evaluations and working capital needs.

Bastion Minerals Limited has announced a non-renounceable pro-rata rights issue to raise approximately $677,721 at a 50% discount to the last trading price. The funds will support ongoing project evaluation and working capital needs.